Nova Financial’s Tvardi Therapeutics TVRD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$10 Buy
+8
New +$17 ﹤0.01% 862

Other funds holding TVRD

Nova Financial's TVRD Position: Q3 2026 in Review

Nova Financial opened a new position in Tvardi Therapeutics (TVRD) in Q3 2026: 8 shares worth $10. The stake represents ﹤0.01% of the portfolio and ranks #862 among its holdings.

61 funds tracked by Wall St. Rank hold TVRD as of Q3 2026.

  • Nova Financial held 8 shares of Tvardi Therapeutics worth $10 as of Q3 2026.
  • Tvardi Therapeutics was a new Nova Financial position in Q3 2026.
  • Tvardi Therapeutics made up ﹤0.01% of Nova Financial's portfolio in Q3 2026, its #862 holding.
  • 61 funds tracked by Wall St. Rank held Tvardi Therapeutics as of Q3 2026.

Based on Nova Financial's 13F filing for Q3 2026, filed 4 Nov 2026.